AlbemarleUS0126531013ALBALB
Financials
Market Cap
$14.78B5Y beta
1.65EPS (TTM)
$13.34Free Float
117.15MP/E ratio (TTM)
9.43Revenue (TTM)
$9.62BEBITDA (TTM)
$881.23MFree Cashflow (TTM)
-$1.01BPricing
Analyst Ratings
The price target is $146.44 and the stock is covered by 26 analysts.
Buy
14
Hold
10
Sell
2
Information
Albemarle Corporation is engaged in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. The Company is a global developer, manufacturer, and marketer of specialty chemicals. Its segments include Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. Its Specialties business optimizes its portfolio of bromine and highly specialized lithium solutions. Its Specialties business serves a variety of industries, including energy, mobility, connectivity, and health. Specialty products are essential in both internal combustion and electric vehicles, from high-voltage cables and powertrains to airbags and tires. Its three main product lines in its Ketjen segment are clean fuels technologies (CFT), fluidized catalytic cracking (FCC) catalysts and additives, and performance catalyst solutions (PCS).